STAB1 and neoplasm: Blockade of STAB1 (with bexmarilimab) followed by transcriptomic analysis demonstrated that TAMs were reprogrammed to enhance production of IL1β, IFNγ, and TNFα; all pro-inflammatory and cytolytic killing of tumor cells.